| scholarly article | Q13442814 |
| P50 | author | Jun-Hu Chen | Q96206508 |
| P2093 | author name string | Xiao-Nong Zhou | |
| Hong Quan | |||
| Shen-Bo Chen | |||
| Wellington Oyibo | |||
| Sunday Omilabu | |||
| Hai-Mo Shen | |||
| Chukwuma Okolie | |||
| Uche Igbasi | |||
| P2860 | cites work | Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis | Q26795623 |
| Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum | Q27861947 | ||
| Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola | Q28125937 | ||
| Origin and evolution of sulfadoxine resistant Plasmodium falciparum | Q28473479 | ||
| Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria | Q28475195 | ||
| Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria | Q28552844 | ||
| Epidemiology of drug-resistant malaria | Q30830669 | ||
| Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review | Q33288230 | ||
| Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based study | Q33568493 | ||
| Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum | Q33680054 | ||
| Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria | Q33889085 | ||
| Antimalarial multi-drug resistance in Asia: mechanisms and assessment | Q33991191 | ||
| Chloroquine-resistant malaria | Q34087800 | ||
| Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. | Q34352253 | ||
| Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? | Q34470236 | ||
| Selective sweeps and genetic lineages of plasmodium falciparum drug -resistant alleles in Ghana | Q34763548 | ||
| Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda | Q35960861 | ||
| The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women | Q35965229 | ||
| Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight | Q36603993 | ||
| Anti-malaria prescription in pregnancy among general practitioners in Enugu state, south east Nigeria | Q36943649 | ||
| Strategies to reverse drug resistance in malaria | Q36987926 | ||
| Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania | Q37262379 | ||
| Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom | Q37274739 | ||
| The evolution of drug-resistant malaria | Q37297141 | ||
| Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V | Q37391118 | ||
| Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria | Q37739425 | ||
| Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria | Q38136762 | ||
| Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains | Q39152224 | ||
| Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. | Q39557015 | ||
| Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection | Q40572417 | ||
| Carriage of Mutant Dihydrofolate Reductase and Dihydropteroate Synthase Genes among Plasmodium falciparum Isolates Recovered from Pregnant Women with Asymptomatic Infection in Lagos, Nigeria | Q40705385 | ||
| Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles | Q41157564 | ||
| Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar | Q41916612 | ||
| Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins | Q41927581 | ||
| Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum | Q41943905 | ||
| Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria | Q43864384 | ||
| Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in v | Q43948272 | ||
| Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole | Q44481689 | ||
| Analysis in Escherichia coli of Plasmodium falciparum dihydropteroate synthase (DHPS) alleles implicated in resistance to sulfadoxine | Q44719097 | ||
| Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria | Q46604202 | ||
| Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum | Q48003670 | ||
| Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria. | Q48021990 | ||
| Origins and spread of novel genetic variants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia | Q60044481 | ||
| High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea | Q64119990 | ||
| Mechanisms of sulfadoxine resistance in Plasmodium falciparum | Q69883752 | ||
| Synergistic Antimalarial Activity of Pyrimethamine and Sulfadoxine against Plasmodium falciparum In Vitro * | Q70360226 | ||
| How does the public perceive healthcare workers in Lagos? A comparison of health workers in public and private health facilities | Q91841943 | ||
| Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis | Q92684763 | ||
| P433 | issue | 1 | |
| P921 | main subject | Nigeria | Q1033 |
| Plasmodium falciparum | Q311383 | ||
| P304 | page(s) | 91 | |
| P577 | publication date | 2020-07-11 | |
| P1433 | published in | Infectious Diseases of Poverty | Q27724786 |
| P1476 | title | High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria | |
| P478 | volume | 9 |
Search more.